U.S. Secretary of Commerce Howard Lutnick attends an interview, extracurricular the White House, successful Washington, D.C., U.S., June 11, 2025.
Kent Nishimura | Reuters
Trump medication subject leaders are "thinking about" whether the U.S. should get equity stakes successful apical defence contractors specified arsenic Lockheed Martin, Commerce Secretary Howard Lutnick said Tuesday.
The Cabinet secretary, successful an interrogation connected CNBC's "Squawk Box," revealed the government's involvement successful taking those stakes days aft the U.S. authorities acquired 10% of Intel banal successful a astir $9 cardinal deal.
Lutnick was asked if the Trump medication would repetition that determination with different companies that bash concern with the government.
"Oh there's a monstrous treatment astir defense," Lutnick replied.
Lockheed, which makes astir of its gross from national contracts, is "basically an limb of the U.S. government," helium said.
"But what's the economics of that? I'm going to permission that to my Secretary of Defense and the lawman Secretary of Defense," helium added.
"These guys are connected it and they're reasoning astir it."
This is breaking news. Please refresh for updates.